Clinical trials for the blood substitute PolyHeme exposed the possibility for ambiguous interpretation of the FDA’s waiver of informed consent for emergency research.
The Epidemic Intelligence Service, by Douglas H. Hamilton, traces the history of the Centers for Disease Control and Prevention’s Epidemic Intelligence Service, with details about the service’s response to actual and potential epidemic outbreaks.
A review of the case of a physician accused of euthanizing four patients following Hurricane Katrina and the state attorney's unethical conduct in releasing information to the media.
Physicians who encounter a patient who is suffering from depression may find it necessary to breach confidentiality and patient autonomy in order to act in the best interest of the patient.
Presymptomatic genetic testing for neurodegenerative diseases can help patients make effective treatment decisions, but the medical profession needs to ensure that the increasing use of the tests is done responsibly.
Physicians are obligated to inform patients involved in a clinical trial that there is a chance of receiving a placebo, which can result in a deterioration of a medical condition.
Physicians are obligated to inform patients involved in a clinical trial that there is a chance of receiving a placebo, which can result in a deterioration of a medical condition.